SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-032535
Filing Date
2024-03-18
Accepted
2024-03-18 08:35:11
Documents
11
Period of Report
2024-03-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K atos-20240315.htm   iXBRL 8-K 40562
  Complete submission text file 0000950170-24-032535.txt   155756

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atos-20240315.xsd EX-101.SCH 27477
14 EXTRACTED XBRL INSTANCE DOCUMENT atos-20240315_htm.xml XML 4494
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 24757009
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)